Human interferon-inducible protein 10 (IP-10), a member of the family of the small secreted proteins called intercrine cytokines or chemokines, is secreted by interferon y-stimulated T cells, monocytes, endothelial cells, and keratinocytes. We have begun to explore the biological properties of IP-10 by cloning and overexpression in baculovirus and in bacterial protein expression systems. A 9.9-kD protein was secreted by infected insect cells, which on sodium dodecyl sulfate-polyacrilamide gel electrophoresis comigrated with keratinocyte IP-10 and with f(22-98), a bacterial recombinant fragment lacking the signal sequence but containing all other residues of IP-10. All three reacted with antibodies recognizing residues 10-98 (ollP-10) and 77-98 of IP-10 (ot22), demonstrating that it is secreted by keratinocytes and insect cells after removal of the signal sequence but without proteolysis of the COOH-terminal end. Purified riP-10 suppresses in vitro colony formation by early human bone marrow progenitor cells which need r-steel factor (rSLF) and rGM-CSF or rSLF and r-erythropoeitin (rEPO). The inhibition is dose dependent, is complete at concentrations >150 ng/ml, is prevented by preincubation of rlP-lO with o~IP-10, but not by c~22, and is seen with highly purified CD34 + cells, suggesting direct effect of riP-10 on the progenitors. Combination of riP-10 and other chemokines at inactive concentrations inhibited colony formation in a synergistic manner, riP-10 did not affect colony formation in the absence of any growth factors or in the presence of rEPO or rGM-CSF but in absence of rSLF. The effects of IP-10 may be relevant to normal marrow function and might be harnessed to protect human hematopoietic progenitors from the cytotoxic effects of chemotherapy.
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W
e have previously cloned human interferon-inducible protein 10 (IP-10), a protein secreted by keratinocytes, monocytes, and human endothelial cells after stimulation by rlFN-y (1, 2) . DNA sequence analysis has demonstrated that IP-10 belongs to the intercrine cytokine or chemokine family of proteins (3, 4) , so named for their chemotactic activity towards neutrophils, monocytes, T cells, basophils, and fibroblasts. Some chemokines inhibit early subsets of bone marrow progenitors (5) (6) (7) (8) (9) (10) (11) . This family is divided in two subgroups based on the arrangement of the first two of four conserved cysteines: the o~-subfamily with the C-X-C motif which is located on human chromosome 4 (q12-21) and includes GRO-a,/~-thromboglobulin, macrophage inflammatory protein (MIP)-2ot, MIP-2B, IL-8, neutrophil-activating peptide (NAP)-2, and IP-10; and the B-subfamily with the C-C motif which is located on human chromosome 17(q11-32) and includes MIP-la, MIP-1B, macrophage-chemotactic and activating factor (MCAF), and RANTES (3, 4) .
We have expressed IP-10 in bacterial and baculovirus vectors and used the purified recombinant protein to investigate its biological activity. We now clarify the model of IP-10 biosynthesis, and demonstrate that it is secreted by keratinocytes and by baculovirus-infected cells after the removal of the signal peptide, but without any detectable processing of the COOHterminal end. Purified riP-10 directly inhibits early subsets of granulocyte/macrophage progenitor cells (CFU-GM), muhipotential granulocyte-erythroid-macrophage-megakaryocytic progenitors (CFU-GEMM) and erythroid burst-forming unit progenitors (BFU-E) that depend on steel factor (rSLF) in addition to rGM-CSF or rEPO, respectively. Inactive concentrations of riP-10 combined with inactive concentrations of rMIP-lo~, rMIP-2o~, platelet factor 4 (PF4), rlL-8, or rMCAF result in synergistic inhibition of early progenitors.
NH2 terminus. The regions adjacent to and including the IP-10 cDNA were sequenced (15) to exclude PCR and cloning errors. Lysogens BL21(DE3) transformed with recombinant plasmids were induced with 0.4 mM isoprol0ylthiogalactoside (18) , recombinant f(22-98) was purified (19) from refractile bodies (20) , dialyzed against Ca/Mg-free PBS, and stored in 1-ml aliquots at -70~ Protein concentration was measured by dye binding (21) . Antiserum AS522 was raised against purified recombinant f(22-98) as described (2) . Natural human IP-10 was concentrated by TCA precipitation of serum-free medium from primary human keratinocytes after 24 h induction by rlFN-3/(2).
Proteins were analyzed on 10020% gradient PAGE with 0.75 M Tris-HC1, pH 8.45, in the stacking gel; 1.0 M Tris-HC1, pH 8.45, in the separating gel; 0.2 M Tris HC1, pH 8.9, in the anode reservoir; 0.1 M Tris-0.1 M Tricine in the cathode reservoir; and 0.1% SDS in all buffers (22) . They were quantitated by densitometry after silver staining (23) . Western blots were performed on Immunobilon-P (16, 24) . riP-10 was immunoprecipitated from [ssS]methionine-labeled Sf9 cells after boiling in 500/~1 of 0.2% SDS-50 mM Tris-HC1, pH 7.5, followed by the sequential addition of NP-40 (final concentration 1%), affinity-purified Abs (final concentration 5/~g/ml), and protein A beads (25) . The relative molecular mass of IP-10 was estimated from the mobilities of marker proteins of 43-14.3 kD. NH2-terminal sequencing was performed as described (26, 27) .
Human bone marrow CFU-GM, BFU-E, and CFU-GEMM of healthy volunteers were assayed as described with added rEPO, rGM-CSF, rSLF (50 ng/ml), and other recombinant or natural chemokines as indicated (6, 7, 11) . Highly purified CD34 § cells (6, 11) were plated (500 cell/ml) in the presence of rEPO (1 U/ml), rSLF (50 ng/ml), rGM-CSF (100 U/ml), and rlLo3 (200 U/ml), and yielded 126 + 10, 60 + 10, and 17 + 5 CFU-GM, BFU-E, and CFU-GEMM per 500 plated cells, respectively. For reversal of inhibition, we preincubated chemokines with fourfold molar excess of affinity-purified Abs (~IP-10 or c~22) or with excess whole serum (AS522) in McCoy's medium at room temperature for 1 h. The mixture was added to human bone marrow cells and CFU-GM were assayed in McCoy's medium supplemented with FCS, rSLF (50 ng/ml), and rGM-CSF (100 U/ml). For control, an equal volume of similarly incubated McCoy's medium was added to cells. Statistical significance was determined with the Student's two-tailed test.
Results
Recombinant baculoviruses 8555, 9094, A213, and A221 express riP-10 as a nonfusion protein. In 8555, the initiating ATG of the polyhedrin gene is mutated to ATT, and protein synthesis starts 118 nucleotides downstream, at the initiating ATG of the IP-10 cDNA. In 9094, the IP-10 was inserted in the same location but in reverse orientation. In A221 and A2D, the initiating ATG of the polyhedrin gene is destroyed by deletion of nucleotides 2-751 of its coding region, and protein synthesis starts eight nucleotides downstream at the initiating ATG of IP-10.
Analysis of protein synthesis after infection by 8555 and A221 demonstrated a major new band of 9.9 kD, similar in size to IP-10 without the signal sequence (10.0 kD), and a minor band of 11.9 ICE), similar in size to IP-10 with the signal sequence (12.4 kD). Neither band was detected in uninfected cells or in cells infected with 9094 or with wild-type virus (Fig. 1 A) . The 9.9-kD but not the 11.9-kD band was de-tected in supernatants of infected cells by autoradiography (data not shown). Nonimmune serum did not precipitate any proteins from ceils infected with A221, but cdP-10 and o~22 precipitated both bands (Fig. 1 B) . Western blotting with cdP-10 and c~22 detected both bands in cells, but only the 9.9-kD band in the medium (data not shown).
To precisdy define the molecular weight of baculovirus IP-10, we used f(22-98) and f(22-77) as molecular weight markers and demonstrated that f(22-98) and IP-10 derived from keratinocytes or baculovirus comigrated at 10.2 kD, and were recognized by olIP-10 and c~22. By contrast, f(22-77) migrated with a relative molecular mass of 6.2 kD, and was recognized by oelP-10 but not by ol22 (Fig. 2) . The reactions of AS522 and c~IP-10 in immunoprecipitations and Western blots were identical (results not shown).
Levels of riP-10 were 5-10 times higher after infection with A213 and A221 than after infection with 8555, and were not affected by FCS reaching 9% of the total protein in the supernatant of cells grown in EXCELL-400 (data not shown). With otlP-10 and a dot blot immunoassay, we purified riP-10 from supernatants of infected cells, and obtained a major peak on HPLC (Fig. 3 A) which was a single band on SDS-PAGE (Fig. 3 B, lanes S, F, and H) comigrating with purified bacterial f(22-98) (Fig. 3 B, lane E) . The faint bands near the top of the gels correspond in size to keratins, and were seen in unloaded lanes or in lanes loaded only with sample buffer. Western blotting confirmed that the purified band represented riP-10, because it reacted with oelP-10 and ol22 during all stages of purification (Fig. 2) . Duplicate membranes were stained with ~IP-10 or ot22.
NHz-terminal sequencing of baculovirus riP-10 demonstrated a major NH2-terminal sequence of VPLSRTVROT (66%) and a minor sequence of RTVROT (34%), both matching the sequence of IP-10 secreted by keratinocytes (2). Sequencing of f(22-98) demonstrated a single sequence of MVPLSRTVR(3rI'OISISNQPVN matching the sequence of secreted IP-10 (2) with an additional NH2-terminal methionine. The yield of purified riP-10 was 0.5 #g/ml of supernatant in the baculovirus system and 5/,g/ml of bacterial culture. 
and (E) purified f(22-98) from Escherichia coil
We evaluated the effect of rlP-lO on colony formation by CFU-GM, BFU-E, and CFU-GEMM. riP-10 (50 and 500 ng/ml) did not affect colony formation by marrow cells plated in medium alone or in the presence of single growth factors (rEPO or rGM-CSF, data not shown). However, riP-10 suppressed colony formation of CFU-GM stimulated by rGM-CSF and rSLF, and BFU-E and CFU-GEMM stimulated by rEPO and rSLF. Concentrations of 1-10 ng/ml were inactive, but there was a dose-dependent inhibition between 25 and 50 ng/ml. Maximal inhibition (50-60%) was seen at 50-500 ng/ml of riP-10 (Fig. 4) , representing complete suppression of the additional CFU-GM and BFU-E or CFU- in the presence of rGM-CSF (100 U/ml) and rSLF (50 ng/ml). CFU-GEMM and BFU-E were plated in the presence of rEPO (1 U/ml) and rSLF (50 ng/ml). Percent inhibition is the mean of three separate experiments with riP-10, and two to three experiments for the other chemokines. Symbols in the graphs are smaller than the SEM, which was always 412% of the mean percent change. Inhibition was based on control colony numbers for CFU-GM (59 + 2 to 106 _+ 7), BFU-E (58 _+ 4 to 105 + 2), and CFU-GEMM GEMM colonies generated by the respective addition of rSLF to rGM-CSF or rEPO (data not shown). The dose-response was similar to that of rMIP-lo6 rMIP-2o~, PF4, rlL-8, or rMCAF (7, 11) which were assessed in the same assays. Whereas individual chemokines were inactive at concentrations <10 ng/ml, significant suppression of colony formation ~ <0.01) was seen when 0.01 ng/ml of riP-10 was combined with 0.01 ng/ml of rMIP-c~, rMIP-2ot, PF4, rlL-8, or rMCAE Combination of 0.1 ng/ml of riP-10 with 0.1 ng/ml of any of these chemokines resulted in a 50-60% inhibition of colony formation by CFU-GM, BFU-E, and CFU-GEMM ~ <0.001). This represented complete inhibition of the rSLF-dependent colonies, and could not be suppressed further with a combination of riP-10, rMIP-lot, rMIP-2, PF4, rlL-8, and rMCAF each at 50 ng/ml (Fig. 4) . In the presence of rlP-lO (100 ng/ml), colony formation by CD34 + cells was inhibited by 77% for CFU-GM ~ <0.01), by 58% for BFU-E (p <0.05), and by 82% for CFU-GEMM (p <0.05).
The inhibitory activity of riP-10 was neutralized by Abs raised against whole IP-10 (cdP-10 and AS522)but not by Abs raised against the 22 COOH-terminal residues of IP-10 (ol22). None of these Abs neutralized the inhibitory activity ofrMIP-lc~ or PF4, or affected the number of colonies grown in the absence of riP-10 ( Table 1) .
Discussion
We had previously suggested that IP-10 was secreted as a 6-7 kD-polypeptide after cotranslational removal of an NH2-terminal signal peptide, and posttranslational proteolysis of the COOH-terminal end. This conclusion was based on two observations, the first being an estimated relative molecular mass of 6-7 kD (2) with SDS-PAGE on polyacrytamide looser than used here (acrylamide/bisacrylamide 30/0.27 vs 30/0.80). Keratinocyte and baculovirus riP-10 comigrated on tricine SDS-PAGE and had a relative molecular mass of 10 kD, suggesting no posttranslational processing of the COOH terminus. However, IP-10 migrates in SDS-PAGE in an area where the mobility of marker proteins is not linearly related to the logarithm of their Mr, and consequently its estimated size could be inaccurate. Keratinocyte and baculovirus IP-10 comigrated with f(22-98), a fragment lacking the signal sequence but retaining all other residues of IP-10, but were larger than f(22-77), which approximates the previously described secreted form of IP-10 without the signal peptide and the last 21 amino acids (2) . Protein sequencing demonstrated that the NH2 terminus of baculovirus IP-10 started at valine 22 of the predicted sequence, and confirmed that Sf9 cells correctly remove the signal peptide.
The second observation supporting the original model was the inability of c~22 to immunoprecipitate keratinocyte IP-10 when nonionic detergent was added first, followed by SDS, Ab, and protein A beads (2) . However, under these conditions, Ag-Ab-protein A interactions are not affected, because free SDS does not reach denaturing levels (28) . When IP-10 was first boiled in SDS followed by the addition of nonionic detergent in amounts sufficient to sequester SDS and permit Ag-Ab interactions, it was immunoprecipitated by odP-10 and oe22. Western blotting confirmed these results. The reactions with antisera, the identity of size, and NH2-terminal sequences of keratinocyte, baculovirus, and f(22-98), demonstrate that IP-10 is secreted without significant processing of its COOH-terminal end. We demonstrated that riP-10 is renatured during purification and has similar biological activity with rMIP-lot, rMIP2c~, PF4, rlL-8, or rMCAF (6, 7, 10, 11), abolishing colony formation by early bone marrow progenitors which require rSLF and rGM-CSF or rSLF and rEPO. Maximally effective concentrations did not abolish all colony formation, because colonies that formed in the absence of rSLF, and that presumably represent later progenitors, were not inhibited by riP-10. The inhibition of colony formation by highly purified CD34 + cells is consistent with a direct effect of riP-10 on early progenitors (11) . The combination of riP-10 and any one of rMIP-lot, rMIP-2ot, PF4, rlL-8, or rMCAF synergistically inhibited colony formation at concentrations 2,500 times lower than required with single chemokines (Fig. 4) , but its molecular basis remains undefined.
The inhibitory activity is intrinsic to purified riP-10, because it was specifically neutralized by Abs against whole IP-10 (odP-10 and AS522), but not by o~22, that recognizes IP-10 only after SDS denaturation. The results of the immunoprecipitations of riP-10 agree with the neutralization of its inhibitory activity, and suggest that the COOH-terminal end is buried in the quaternary structure of the native protein. Quantities of natural IP-10 are too small for purification of amounts sufficient for investigation of its biological activity. The demonstration that riP-10 has the same specific activity as the other chemokines in the colony suppression assay, supports the notion that bacteria and insect cells generate a protein with the correct disulfide arrangements, and that the purification of riP-10 results in a completely renatured product. Therefore, the inability of riP-10 to activate neutrophils (Wirthmueller, U., A. Sarris, and M. Baggiolini, unpublished observations and 29), or to stimulate the growth of melanoma cells (Richmont, A., and A. Sarris, unpublished observations), probably reflect properties of the naturally occurring protein.
Since intravenous administration of rMIP-lot protected mufine hematopoietic progenitors from hydroxyurea and cytosine arabinoside (8, 9) , riP-10 may also be protective, and may become clinically useful by allowing repetitive chemotherapy administration without stem cell depletion.
